Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: Doug B. who wrote (8)	8/3/1999 4:07:00 PM
From: hoyasaxa	Respond to of 746

Appears like you have CRA, Incyte, Human Genome as pure plays (that I believe can co-exist, not a winner-take-all race unless one way faster than the others) with companies like LabCorp (LH) -- which does geno-typing and pheno-typing testing and Big Pharma -- which will make drugs based on the genetic map -- as also profiting handsomely from the endeavor.... As for the rest of Doug's questions, see the latest 10-Q and PE's registration document for the tracking stock.....